Annual EBITDA
$1.21B$420.00M-25.80%
Summary
- Current Value
- As of today, SOLV annual EBITDA is $1.21B, down -25.80% on
- Historical Performance
- SOLV annual EBITDA is down -46.81% over the past 3 years, down -40.46% over the past 5 years
- All-Time High Comparison
- SOLV annual EBITDA is currently -51.21% below its historical high of $2.48B set on
- 3-Year Low Comparison
- SOLV annual EBITDA is at its 3-year low
- Sector Comparison
- SOLV annual EBITDA is higher than 93.65% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.21B | -25.8% | -46.8% | -40.5% | -40.5% | |
| Quarterly EBITDA | $345.00M | -44.5% | -37.3% | -38.9% | -38.9% | |
| TTM EBITDA | $1.18B | -29.3% | -45.2% | +109.6% | +109.6% | |
| Price | $87.45 | +23.6% | – | – | – | |
| PE Ratio | 10.69 | -67.2% | – | – | – | |
| Annual Revenue | $8.33B | +0.9% | +2.4% | +14.3% | +14.3% | |
| Annual EPS | $8.88 | +221.9% | +14.2% | +34.7% | +34.7% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Annual Net Income | $1.56B | +224.8% | +15.9% | +36.7% | +36.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.27B | N/A | -46.8% |
| 5Y | $2.48B | -51.2% | |
| All | $2.48B | -51.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.21B | at low | |
| 5Y | $1.21B | at low | |
| All | $1.21B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $1.21B | -25.8% | |
| $1.63B | -27.7% | |
| $2.25B | -0.8% |
| Year | Value | Change |
|---|---|---|
| $2.27B | -8.3% | |
| $2.48B | +22.0% | |
| $2.03B | - |
FAQ
- What is the current annual EBITDA of SOLV?
- As of today, SOLV annual EBITDA is $1.21B
- What is 1-year change in SOLV annual EBITDA?
- SOLV annual EBITDA is down -25.80% year-over-year
- What is 3-year change in SOLV annual EBITDA?
- SOLV annual EBITDA is down -46.81% over the past 3 years
- How far is SOLV annual EBITDA from its all-time high?
- SOLV annual EBITDA is currently -51.21% below its historical high of $2.48B set on December 1, 2021
- How does SOLV annual EBITDA rank versus sector peers?
- SOLV annual EBITDA is higher than 93.65% of companies in Healthcare sector
- When is SOLV next annual earnings release?
- As of today, the next annual earnings release for SOLV has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$345.00M$93.00M+36.90%
Summary
- Current Value
- As of today, SOLV quarterly EBITDA is $345.00M, up +36.90% on
- Historical Performance
- SOLV quarterly EBITDA is down -44.53% year-over-year, down -37.27% over the past 3 years
- All-Time High Comparison
- SOLV quarterly EBITDA is currently -46.76% below its historical high of $648.00M set on
- 3-Year Low Comparison
- SOLV quarterly EBITDA is +36.90% above its 3-year low of $252.00M reached on
- Sector Comparison
- SOLV quarterly EBITDA is higher than 93.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $345.00M | +36.9% | -44.5% | -37.3% | -38.9% | |
| Annual EBITDA | $1.21B | – | -25.8% | -46.8% | -40.5% | |
| TTM EBITDA | $1.18B | -19.0% | -29.3% | -45.2% | +109.6% | |
| Price | $87.45 | +14.9% | +23.6% | – | – | |
| PE Ratio | 10.69 | +14.7% | -67.2% | – | – | |
| Quarterly Revenue | $2.21B | +10.1% | +1.2% | +6.4% | +10.0% | |
| Quarterly EPS | $0.53 | +616.5% | +3.4% | -71.4% | -72.6% | |
| $219.00M | +76.6% | -56.2% | -47.5% | -48.2% | ||
| Quarterly Net Income | $92.00M | +607.7% | +2.2% | -71.3% | -72.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $622.00M | N/A | -44.5% |
| 3Y | $648.00M | -46.8% | |
| 5Y | $648.00M | -46.8% | |
| All | $648.00M | -46.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $252.00M | +36.9% | |
| 3Y | $252.00M | +36.9% | |
| 5Y | $252.00M | +36.9% | |
| All | $252.00M | +36.9% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of SOLV?
- As of today, SOLV quarterly EBITDA is $345.00M
- What is SOLV quarterly EBITDA most recent change?
- SOLV quarterly EBITDA was up +36.90% on June 30, 2026
- What is 1-year change in SOLV quarterly EBITDA?
- SOLV quarterly EBITDA is down -44.53% year-over-year
- How far is SOLV quarterly EBITDA from its all-time high?
- SOLV quarterly EBITDA is currently -46.76% below its historical high of $648.00M set on September 30, 2023
- How does SOLV quarterly EBITDA rank versus sector peers?
- SOLV quarterly EBITDA is higher than 93.54% of companies in Healthcare sector
- When is SOLV next earnings release?
- The next earnings release for SOLV is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$1.18B$277.00M-18.96%
Summary
- Current Value
- As of today, SOLV TTM EBITDA is $1.18B, down -18.96% on
- Historical Performance
- SOLV TTM EBITDA is down -29.27% year-over-year, down -45.19% over the past 3 years
- All-Time High Comparison
- SOLV TTM EBITDA is currently -47.68% below its historical high of $2.26B set on
- 3-Year Low Comparison
- SOLV TTM EBITDA is at its 3-year low
- Sector Comparison
- SOLV TTM EBITDA is higher than 93.45% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.18B | -19.0% | -29.3% | -45.2% | +109.6% | |
| Annual EBITDA | $1.21B | – | -25.8% | -46.8% | -40.5% | |
| Quarterly EBITDA | $345.00M | +36.9% | -44.5% | -37.3% | -38.9% | |
| Price | $87.45 | +14.9% | +23.6% | – | – | |
| PE Ratio | 10.69 | +14.7% | -67.2% | – | – | |
| TTM Revenue | $8.31B | +0.3% | -1.2% | +2.6% | +313.6% | |
| TTM EPS | $8.18 | +0.2% | +276.9% | +12.5% | +321.8% | |
| $705.00M | -28.5% | -38.3% | -55.6% | +66.7% | ||
| TTM Net Income | $1.43B | +0.1% | +278.4% | +14.2% | +328.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.67B | N/A | -29.3% |
| 3Y | $2.26B | -47.7% | |
| 5Y | $2.26B | -47.7% | |
| All | $2.26B | -47.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.18B | at low | |
| 3Y | $1.18B | at low | |
| 5Y | $565.00M | +109.6% | |
| All | $565.00M | +109.6% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of SOLV?
- As of today, SOLV TTM EBITDA is $1.18B
- What is SOLV TTM EBITDA most recent change?
- SOLV TTM EBITDA was down -18.96% on June 30, 2026
- What is 1-year change in SOLV TTM EBITDA?
- SOLV TTM EBITDA is down -29.27% year-over-year
- How far is SOLV TTM EBITDA from its all-time high?
- SOLV TTM EBITDA is currently -47.68% below its historical high of $2.26B set on March 31, 2024
- How does SOLV TTM EBITDA rank versus sector peers?
- SOLV TTM EBITDA is higher than 93.45% of companies in Healthcare sector
- When is SOLV next earnings release?
- The next earnings release for SOLV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- SOLV Official Website www.solventum.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.htm
- SOLV Profile on Yahoo Finance finance.yahoo.com/quote/SOLV
- SOLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/solv